ER/PgR phenotypes | Breast cancer HER2 status | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
0+ | 1+ | 2+ | 3+ | |||||||
ERÂ +Â PgR+ | Cancer types | Luminal A/B1 | Luminal B2 | |||||||
EM clusters | LMA | IMA | LMA | IMA | LMA | IMA | LMA | IMA | ||
Patients | n | 255 | 83 | 187 | 46 | 52 | 11 | 139 | 26 | |
% | 75.4 | 24.6 | 80.3 | 19.7 | 82.5 | 17.5 | 84.2 | 15.0 | ||
Mean Ki-67% | 9.5 | 39.1 | 11.3 | 39.6 | 13.5 | 38.6 | 19.2 | 56.6 | ||
St.dev. of Ki-67 | 6.1 | 15.2 | 7.2 | 11.1 | 6.9 | 9.5 | 10.1 | 10.3 | ||
ERÂ +Â PgR- | Cancer types | Luminal A/B1 | Luminal B2 | |||||||
EM clusters | LMA | IMA | LMA | IMA | n/a | LMA | IMA | |||
Patients | n | 15 | 10 | 20 | 6 | 7 | 31 | 2 | ||
% | 60.0 | 40.0 | 76.9 | 23.1 | n/a | 93.9 | 6.1 | |||
Mean Ki-67% | 9.7 | 42.4 | 15.5 | 39.0 | 25.4 | 60.0 | ||||
St.dev. of Ki-67 | 5.4 | 14.8 | 8.6 | 6.0 | 13.3 | 7.1 | ||||
ER-PgR- | Cancer types | triple-negative | pure HER2 | |||||||
EM clusters | IMA | HMA | IMA | HMA | n/a | IMA | HMA | |||
Patients | n | 63 | 43 | 29 | 11 | 8 | 111 | 14 | ||
% | 59.4 | 40.6 | 72.5 | 27.5 | n/a | 88.8 | 11.2 | |||
Mean Ki-67% | 34.0 | 79.0 | 32.3 | 82.7 | 32.4 | 73.2 | ||||
St.dev. of Ki-67 | 18.3 | 6.4 | 18.1 | 8.5 | 14.7 | 8.7 |